Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Drug Topics Community Pharmacists' Report

Drug Topics
Community
Pharmacists' Report

DrugTopics.com

February 15, 2012

CHAINS & BUSINESS

More patients pick up e-prescriptions than paper prescriptions

More patients pick up their first prescription when it’s sent to the pharmacy electronically than when it’s given to the patient on paper, according to the results of a study conducted by an e-prescribing network. » More

CVS/pharmacy’s Project Health offering 1,000 screening events in 2012

CVS/pharmacy is planning 1,000 health-screening events across the country this year, as part of its new multicultural Project Health program. » More

Target will allow individual pharmacy owners in its Canadian stores

Target will allow individual pharmacy owners in Canada to own pharmacies within the company’s stores, departing from its policy in the United States, the company said. » More

CONTINUING EDUCATION

Cardiometabolic disease: The pharmacist’s role in managing weight loss and medication adherence

Pharmacists can help with the management of weight loss through nutrition education, exercise counseling, and strategies for medication adherence.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login and take the exams.

MEDICATION SAFETY

Checking side effects: Pharmacist creates an app for that

Matthew Murawski, PharmD, has a new tool to help catch potential medication interactions before they happen: an iPad. » More

FDA ACTIONS

FDA issues 3 draft guidances on biosimilars

FDA has issued 3 draft guidances for the development of biosimilar versions of approved biologic products, which will help flesh out the abbreviated approval pathway created by the Patient Protection and Affordable Care Act signed into law in 2010. » More

FDA extends approval for drug to treat adult ADHD

FDA has approved lisdexamfetamine dimesylate (Vyvanse, Shire) capsules, (CII) as a maintenance treatment for adults with ADHD. Vyvanse was already approved as a treatment for ADHD in patients aged 6 to 17 years. » More

ASSOCIATION NEWS

Two members of Congress urge support for MTM Benefits Act

Two U.S. congressional representatives recently urged other members of the House of Representatives to support the Medication Therapy Management Benefits Act of 2011. » More

NCPA tells Congress: Drug shortages mean higher costs, fewer prescriptions filled

Drug shortages have resulted in higher acquisition costs for pharmacies and the inability to fill prescriptions, according to a new survey, and the National Community Pharmacists Association conveyed that message to Congress. » More

Survey

Does your employer allow the use of your doctor degree on your name tag?

a) Yes, my employer allows PharmD after my name or the use of the title Dr. before my name.
b) Yes, my employer allows PharmD after my name but not the title Dr. before my name.

c) No, my employer does not allow any doctor title before or after my name.


Respond here and see what your colleagues think, too.

Want to see the results of our last survey about whether pharmacists should have the authority to prescribe medications? Click here.

 
Twitter  

Follow us on Twitter

Voices

DT Blog

JP at Large

View from the Zoo

Viewpoints

Regulatory & Legal

 

Meetings & Events

Digital Edition

View current edition

Cover
 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.